You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Open triple therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

Not yet recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • (no location specified)
Jun 11, 2023

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Taxane and Carboplatin
  • +2 more
  • (no location specified)
Apr 25, 2023

COPD Trial in United States (Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) 320 µg/18 µg/9.6 µg administered

Not yet recruiting
  • COPD
  • Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) 320 μg/18 μg/9.6 μg administered as two inhalations, twice daily.
  • External Comparator
  • Tampa, Florida
  • +6 more
Jul 21, 2023

Triple-Negative Breast Cancer Trial in Taiwan (EndoTAG-1, Paclitaxel, Gemcitabine Hydrochloride)

Suspended
  • Triple-Negative Breast Cancer
  • Kaohsiung, Taiwan
  • +5 more
Dec 6, 2022

Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Sacituzumab govitecan-hziy (SG)
  • +2 more
  • Glendale, Arizona
  • +7 more
Jan 26, 2023

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Metastatic Triple-Negative Breast Carcinoma Trial (PVX-410)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • (no location specified)
Apr 18, 2022

Advanced Triple Negative Breast Cancer Trial in Newport Beach (N-803, PD-L1 t-haNK, Sacituzumab Govitecan-Hziy)

Active, not recruiting
  • Advanced Triple Negative Breast Cancer
  • N-803
  • +3 more
  • Newport Beach, California
    Hoag Memorial Hospital
Mar 29, 2022

Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)

Recruiting
  • Primary Open-angle Glaucoma
  • Bogotá, Bogotá D.C., Colombia
  • +1 more
Dec 22, 2021

Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)

Recruiting
  • Triple-negative Breast Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Apr 14, 2022

Cystic Fibrosis Trial (VNZ/TEZ/D-IVA)

Not yet recruiting
  • Cystic Fibrosis
  • (no location specified)
Apr 24, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • Artemether-Lumefantrine-Amodiaquine (ALAQ)
  • +2 more
  • (no location specified)
Jul 20, 2023

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Gastritis, Peptic Ulcer, Dyspepsia Trial in Xi'an (Clostridium butyricum capsule, esomeprazole, amoxicillin)

Completed
  • Gastritis
  • +2 more
  • Clostridium butyricum capsule
  • +5 more
  • Xi'an, Shanxi, China
    Xijing Hospital of Digestive Diseases
Feb 8, 2022

Triple Negative Breast Cancer Trial in Guangzhou (Sintilimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    NeoSACT
Oct 9, 2021

COVID-19, Virus Diseases, Corona Virus Infection Trial in Athens (Sodium Thiosulfate 25% Solution for Injection)

Recruiting
  • COVID-19
  • +2 more
  • Sodium Thiosulfate 25% Solution for Injection
  • Athens, Kifisia, Greece
    General Hospitan of Athens KAT 2nd Department of ICU
Jan 11, 2023

Urothelial Bladder Cancer, Triple-negative Breast Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Tremelimumab

Active, not recruiting
Has Results
  • Urothelial Bladder Cancer
  • +2 more
  • Tremelimumab monotherapy
  • +2 more
  • San Francisco, California
  • +13 more
Jan 20, 2023

NSCLC, Triple Negative Breast Tumors, Squamous Cell Carcinoma of Head and Neck Trial in United States (Pembrolizumab, TAK-676,

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • West Hollywood, California
  • +5 more
Mar 17, 2022

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
Has Results
  • Triple-negative Breast Cancer
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

Triple Negative Breast Cancer Trial in Lausanne (stereotactic body radiotherapy, CMP-001)

Recruiting
  • Triple Negative Breast Cancer
  • stereotactic body radiotherapy
  • CMP-001
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jul 6, 2021

Helicobacter Pylori Infection Trial in Ljubljana (Bismuth Subcitrate)

Recruiting
  • Helicobacter Pylori Infection
  • Bismuth Subcitrate
  • Ljubljana, Slovenia
    Matjaž Homan
Nov 19, 2023

Helicobacter Pylori Infection Trial in Seoul (Tegoprazan 50 mg Triple Therapy, Tegoprazan 100 mg Triple Therapy, Lansoprazole

Recruiting
  • Helicobacter Pylori Infection
  • Tegoprazan 50 mg Triple Therapy
  • +2 more
  • Seoul, Korea, Republic of
    Chung-Ang University Hosptial
Jul 3, 2023